Welcome to our newsroom. Here you will find all the latest news about Brystol Myers Squibb in the Netherlands. As a journalist, you will also find all press releases, contact details and visual material here.

Latest news

Topping-off ceremony
Bristol Myers Squibb celebrates highest point of first European cell therapy production facility at Leiden Bio Science Park  >

The construction of the CAR T cell therapy production centre of Bristol Myers Squibb in the Leiden Bio Science Park (LBSP) is going fast. Today the highest point was reached which traditionally means a topping-off ceremony. 

Immunotherapy reimbursed for cancer patients with a rare tumor profile who no longer have other treatment options >
World MS day
#MSconnections on World MS Day >

World MS Day is coming up on May 30, 2022: a day for the global MS community to come together and share their stories; offering each other support, but also creating more awareness about the truth of living with multiple sclerosis (MS). In honour of this day, Evelijne from Bristol Myers Squibb was asked to be a guest host of the Instagram page of Platform MS, one of the largest online communities for MS patients in the Netherlands. Every week someone new gets the chance to tell his/her story via the page.

For all media inquiries

Contact us for more information or to receive press material.


Ronald Jager

Senior Manager Corporate Affairs


Phone number: +31 30 300 22 22




If you are not a member of the press and have a non-media related question then find the right contact information here. This will enable us to help you faster!

Corporate Publications

Diversity & Inclusion Report
Diversity & Inclusion Report 2021
Sustainability Report
Sustainability Report 2020

In short

Who are we?

Learn more about the mission, vision and values of Bristol Myers Squibb the Netherlands

Facts and figures

The most important facts and figures at a glance

Our medicines

More information about the medicines distributed by Bristol Myers Squibb in The Netherlands

Our Research

Get an overview of our research for innovative medicines